Banys-Paluchowski M, Hartmann S, de Boniface J, Gentilini OD, Ditsch N, Stickeler E, Karadeniz Cakmak G, Hauptmann M, Schroth J, Thill M, di Micco R, Hahn M, Murawa D, Rubio IT, Pinto D, Kontos M, Niinikoski L, Gasparri ML, Nina H, Rebaza LP, Fröhlich S, Schmidt E, Wihlfahrt K, Berger T, Basali T et al. (2026)
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study
J Clin Oncol, JCO2501921 (in press)
DOI 10.1200/JCO-25-01921, PubMed 41564379

Montagna G, Alvarado M, Myers S, Mrdutt MM, Sun SX, Sevilimedu V, Barrio AV, van den Bruele AB, Boughey JC, Boyle MK, Crown A, Kesmodel SB, King TA, Kuerer HM, Leisha EC, Moo TA, Weiss A, Williams AD, Parmar P, Diskin B, Hlavin C, Diego EJ, Polidorio N, Abdelwahab K, Banys-Paluchowski M et al. (2026)
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study
Lancet Oncol, 27 (1), 57-67
DOI 10.1016/S1470-2045(25)00598-4, PubMed 41449148

Kühn T, Banys-Paluchowski M, Ditsch N, Stickeler E, Hauptmann M, Schroth J, Karadeniz Cakmak G, Hahn M, Thill M, Reimer T, Fröhlich S, Schmidt E, Wihlfahrt K, Berger T, Basali T, Ruf F, Rief A, Lux MP, Kolberg HC, Rubio IT, Gasparri ML, Kontos M, Bonci EA, Niinikoski L, Murawa D et al. (2025)
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study
Br J Surg, 112 (9)
DOI 10.1093/bjs/znaf180, PubMed 40966675